Market Overview:
The global doxycycline hyclate market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of infectious diseases, rising demand for generic drugs, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global doxycycline hyclate market can be segmented into pharmaceutical grade and veterinary grade. The pharmaceutical grade segment is expected to account for a larger share of the global doxycycline hyclate market than the veterinary grade segment during the forecast period. This can be attributed to factors such as rising demand for antibiotics and increasing awareness about hygiene and sanitation among consumers across regions. Based on application, the global doxycycline hyclate market can be divided into capsules, tablets, and injections.
Product Definition:
Doxycycline Hyclate is an antibiotic that is used to treat a number of infections, including acne, chlamydia, and gonorrhea. It is also sometimes used to prevent malaria. Doxycycline Hyclate is important because it can effectively treat a number of different infections while also being relatively safe for use.
Pharmaceutical Grade:
Pharmaceutical grade doxycycline hyclate is a semi-synthetic tetracycline antibiotic drug used to treat bacterial infections. It works by inhibiting the protein synthesis in bacteria, thereby preventing the growth of bacteria. Doxycycline hyclate capsules are light yellow colored and have a score line down one side which indicates its enteric coated property.
Veterinary Grade:
Veterinary grade doxycycline hyclate is a tetracycline antibiotic used in the treatment of bacterial infections in animals. It is also known as 4-D or V-CyCline and has been approved by the U.S Food and Drug Administration (FDA) for use in humans as well as animals, hence it can be commercially sold over the counter without a prescription.
Application Insights:
Doxycycline hyclate capsule was the most prominent application of doxycycline and accounted for over 60% of the total revenue in 2017. The product is used to treat infections caused by bacteria, such as skin infections, urinary tract infections (UTIs), respiratory tract infections (RTIs), and gastrointestinal (GI) illnesses. Doxycycline capsules are highly effective against a wide range of pathogens including Mycoplasma pneumoniae, Haemophilus influenzae type b (Hib) bacteria, Staphylococcus aureus bacteria and Streptococcus pneumoniae.
The antibiotic is available as an oral tablet formulation in various dosage forms such as 200 mg & 400 mg with or without food for adults; 100 mg/5 ml for children above 8 years; 80 mg/3ml & 160mg/8ml for infants below 8 years of age respectively.
Regional Analysis:
North America was the second-largest regional market for doxycycline hyclate, in terms of revenue, in 2017. The region is expected to maintain its dominance over the forecast period owing to increasing R&D activities and high adoption of innovative drugs. Moreover, presence of major players with wide distribution networks will help North America maintain its position during the forecast period.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast years due to rising healthcare spending by developing countries such as China and India along with other South East Asian countries. In addition, increasing awareness about treatment options among patients is also expected favorably impact growth rate in this region over next eight years.
Growth Factors:
- Increasing prevalence of infectious diseases: The increasing prevalence of infectious diseases is one of the major growth drivers for the Doxycycline Hyclate market. According to the World Health Organization, around 2 billion people are affected by one or more infectious diseases every year and this number is estimated to increase in the coming years. This will create a high demand for Doxycycline Hyclate products and drive the market growth.
- Rising awareness about preventive measures: There is an increasing awareness among people about preventive measures against infections and this is driving the demand for Doxycycline Hyclate products. People are now more inclined towards taking prophylactic measures to avoid infections, which is boosting the market growth.
- Growing geriatric population: The global geriatric population is growing at a rapid pace and this is creating a high demand for effective antibiotics such as Doxycycline Hyclate products. Elderly people are more susceptible to various types of infections and thus require timely treatment with effective antibiotics such as doxycycline hyclate tablets 100mg, which will fuel market growth in future years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Doxycycline Hyclate Market Research Report
By Type
Pharmaceutical Grade, Veterinary Grade
By Application
Doxycycline Hyclate Capsule, Doxycycline Hyclate Tablets, Doxycycline Hyclate Injection
By Companies
Jiangsu Lianhuan Pharma, Changzhou Pharmaceutical Factory, Sun Pharma, Spansules Pharma, Raks Pharma, Hovione, LGM Pharma, Kunshan Chemical & Phatmaceutical, Houyi Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Doxycycline Hyclate Market Report Segments:
The global Doxycycline Hyclate market is segmented on the basis of:
Types
Pharmaceutical Grade, Veterinary Grade
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Doxycycline Hyclate Capsule, Doxycycline Hyclate Tablets, Doxycycline Hyclate Injection
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jiangsu Lianhuan Pharma
- Changzhou Pharmaceutical Factory
- Sun Pharma
- Spansules Pharma
- Raks Pharma
- Hovione
- LGM Pharma
- Kunshan Chemical & Phatmaceutical
- Houyi Group
Highlights of The Doxycycline Hyclate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceutical Grade
- Veterinary Grade
- By Application:
- Doxycycline Hyclate Capsule
- Doxycycline Hyclate Tablets
- Doxycycline Hyclate Injection
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Doxycycline Hyclate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Doxycycline Hyclate is a tetracycline antibiotic. It is used to treat a variety of infections, including acne, bronchitis, and sinus infections.
Some of the key players operating in the doxycycline hyclate market are Jiangsu Lianhuan Pharma, Changzhou Pharmaceutical Factory, Sun Pharma, Spansules Pharma, Raks Pharma, Hovione, LGM Pharma, Kunshan Chemical & Phatmaceutical, Houyi Group.
The doxycycline hyclate market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Doxycycline Hyclate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Doxycycline Hyclate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Doxycycline Hyclate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Doxycycline Hyclate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Doxycycline Hyclate Market Size & Forecast, 2020-2028
4.5.1 Doxycycline Hyclate Market Size and Y-o-Y Growth
4.5.2 Doxycycline Hyclate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Pharmaceutical Grade
5.2.2 Veterinary Grade
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Doxycycline Hyclate Capsule
6.2.2 Doxycycline Hyclate Tablets
6.2.3 Doxycycline Hyclate Injection
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Doxycycline Hyclate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Doxycycline Hyclate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Pharmaceutical Grade
9.6.2 Veterinary Grade
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Doxycycline Hyclate Capsule
9.10.2 Doxycycline Hyclate Tablets
9.10.3 Doxycycline Hyclate Injection
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Pharmaceutical Grade
10.6.2 Veterinary Grade
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Doxycycline Hyclate Capsule
10.10.2 Doxycycline Hyclate Tablets
10.10.3 Doxycycline Hyclate Injection
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Pharmaceutical Grade
11.6.2 Veterinary Grade
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Doxycycline Hyclate Capsule
11.10.2 Doxycycline Hyclate Tablets
11.10.3 Doxycycline Hyclate Injection
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Pharmaceutical Grade
12.6.2 Veterinary Grade
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Doxycycline Hyclate Capsule
12.10.2 Doxycycline Hyclate Tablets
12.10.3 Doxycycline Hyclate Injection
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Pharmaceutical Grade
13.6.2 Veterinary Grade
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Doxycycline Hyclate Capsule
13.10.2 Doxycycline Hyclate Tablets
13.10.3 Doxycycline Hyclate Injection
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Doxycycline Hyclate Market: Competitive Dashboard
14.2 Global Doxycycline Hyclate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Jiangsu Lianhuan Pharma
14.3.2 Changzhou Pharmaceutical Factory
14.3.3 Sun Pharma
14.3.4 Spansules Pharma
14.3.5 Raks Pharma
14.3.6 Hovione
14.3.7 LGM Pharma
14.3.8 Kunshan Chemical & Phatmaceutical
14.3.9 Houyi Group
